Digest Network Come funziona
Network
/
Società
Bi
Non verificato

Bioxodes

Di cosa scriviamo

Annunci EconomiciBiotecnologiaMedicina Salute Benessere

5 comunicati stampa

Guarda tutti i comunicati
27/04/2026
Biotecnologia
Medicina Salute Benessere
Bioxodes to present final Phase 2a trial results confirming breakthrough potential of BIOX-101 for intracerebral hemorrhage in poster at ESOC 2026
Fonte
Bioxodes
Emittente
GLOBENEWSWIRE
1.00
0
16/04/2026
Biotecnologia
Annunci Economici
Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage
Fonte
Bioxodes
Emittente
GLOBENEWSWIRE
1.00
0
09/12/2025
Biotecnologia
Medicina Salute Benessere
Bioxodes lève 5,5 millions d'euros dans le cadre d'une extension de la Série A afin de poursuivre la préparation d’un essai pivot pour son candidat-médicament innovant dans le traitement de l'AVC
Fonte
Bioxodes
Emittente
GLOBENEWSWIRE
1.00
0
09/12/2025
Biotecnologia
Medicina Salute Benessere
Bioxodes raises €5.5 million Series A extension to continue preparations for pivotal trial of breakthrough stroke candidate
Fonte
Bioxodes
Emittente
GLOBENEWSWIRE
1.00
0
13/11/2025
Biotecnologia
Annunci Economici
Bioxodes presents BIOX-101 clinical data showing breakthrough potential for stroke in webcast with Prof Dr Robin Lemmens
Fonte
Bioxodes
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0